Healthcare -
Biotechnology - NASDAQ - US
$ 3.6301
4.61 %
$ 2.65 B
Market Cap
-4.03
P/E
IBRX - INTEREST INCOME & EXPENSE
Interest Income & Expense IBRX - ImmunityBio, Inc.
129 M
LAST VALUE
194.97%
2 YEAR CAGR
212.57%
5 YEAR CAGR
75.62%
10 YEAR CAGR